Impact of transurethral plasmamakinetic enucleation surgery in treating elderly patients with benign mass hyperplasia on prostate symptom score and life quality

Abstract

Objective To evaluate the impact of transurethral plasmamakinetic enucleation surgery(TUPKEP) in treating elderly patients with benign mass hyperplasia on prostate symptom score and life quality. Methods From March 2012 to September 2014, 128 elderly patients benign mass hyperplasia in our hospital were selected and 78 patients who were treated with TUPKEP was taken as TUPKEP group while the other 50 patients who underwent transurethral resection of prostate(TURP) was taken as TURP group. Operation conditions, international prostate symptom score (IPSS) and quality of life score (SF-36) and adverse reactions and complications of two groups before and after treatment were compared. Results Compared with TURP group, urinary catheter placing time and postoperative hospital stay time of TUPKEP group were shorter, the operation time of TUPKEP group was longer, intraoperative blood loss and postoperative bladder residual urine volume of TUPKEP group were reduced, and prostate tissue removal and the maximum urine flow rate of TUPKEP group were increased (P 0.05). Conclusions TUPKEP in the treatment of elderly patients with benign mass hyperplasia has some advantages of less surgery trauma, low complications and recurrence rate for improving the recovery and life quality, therefore, TUPKEP in the treatment of elderly patients with benign mass hyperplasia has good feasibility and safety, and is worthy of clinical use. Key words: Prostatic Hyperplasia; Transurethral Resection of Prostate; Quality of Life